Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
€ 5,17 ↓ -0.02 (-0.39%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership191,036 shares
Latest Disclosed Value $ 1,684,938
Barclays Plc ownership in VM4 / Vanda Pharmaceuticals Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 191,036 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $1,193,975 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 222,579 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of -14.17% during the quarter. The current value of the position is $987,656 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (VM4) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VM4 / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 191,036 -31,543 -14.17 1,685 51.71 0.0004
2026-03-31 2025-09-30 13F/A-3 VANDA PHARMACEUTICALS COM 921659108 222,579 -1,825 -0.81 1,111 4.82 0.0002
2026-03-19 2025-09-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 154,297 -70,107 724 0.0002
2025-11-12 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 222,579 -1,825 1,111 0.0002
2026-02-27 2025-06-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 224,404 56,311 33.50 1,059 37.35 0.0002
2025-08-14 2025-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 224,404 56,311 1 0.0002
2025-08-13 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 224,404 56,311 1 0.0001
2026-03-17 2025-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 168,093 -10,275 -5.76 772 -9.72 0.0002
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 168,093 -10,275 1 0.0002
2026-03-19 2024-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 178,368 24,071 15.60 854 18.12 0.0002
2025-02-13 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 178,368 24,071 1 0.0002
2026-03-31 2024-09-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 154,297 86,677 128.18 724 89.27 0.0002
2024-11-19 2024-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 154,297 86,677 1 0.0002
2024-11-15 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 154,297 86,677 1 0.0001
2026-03-23 2024-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 67,620 -58,056 -46.19 382 -25.97 0.0001
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 67,620 -58,056 0 0.0001
2026-03-24 2024-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 125,676 -45,962 -26.78 517 -28.73 0.0002
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 125,676 -45,962 1 0.0002
2026-03-25 2023-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 171,638 43,308 33.75 724 30.69 0.0003
2024-02-15 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 171,638 43,308 1 0.0003
2026-03-26 2023-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 128,330 3,265 2.61 554 -32.77 0.0003
2023-11-07 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 128,330 3,265 1 0.0003
2026-03-30 2023-06-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 125,065 24,771 24.70 824 21.18 0.0005
2023-09-20 2023-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 125,065 24,771 1 0.0005
2023-08-03 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 125,065 24,771 1 0.0005
2026-03-30 2023-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 100,294 3,550 3.67 681 -4.76 0.0003
2023-05-04 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 100,294 3,550 1 0.0003
2026-03-30 2022-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 96,744 -2,558 -2.58 715 -27.22 0.0003
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 96,744 -2,558 1 0.0003
2022-11-03 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 99,302 81,044 443.88 981 392.96 0.0011
2022-08-12 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 18,258 -26,511 -59.22 199 -60.75 0.0001
2022-05-16 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 44,769 -26,872 -37.51 507 -54.89 0.0004
2022-02-23 2021-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 71,641 14,839 26.12 1,124 15.40 0.0004
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 71,641 14,839 1,124 0.0004
2021-11-09 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 56,802 22,912 67.61 974 33.61 0.0004
2021-08-13 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 33,890 -63,808 -65.31 729 -50.31 0.0003
2021-05-13 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 97,698 15,309 18.58 1,467 35.46 0.0008
2021-02-11 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 82,389 -24,920 -23.22 1,083 4.64 0.0006
2020-11-12 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 107,309 10,270 10.58 1,035 -6.67 0.0006
2020-08-12 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 97,039 23,690 32.30 1,109 45.92 0.0009
2020-05-13 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 73,349 -16,442 -18.31 760 -48.40 0.0006
2020-02-10 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 89,791 14,215 18.81 1,473 46.86 0.0008
2019-11-15 2019-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 75,576 -15,041 -16.60 1,003 -21.39 0.0006
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 75,576 -15,041 1,003 231.8947
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 90,617 23,128 34.27 1,276 2.65 0.0008
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 67,489 43,754 184.34 1,243 100.48 0.0009
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 23,735 -41,497 -63.61 620 -58.58 0.0005
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 65,232 58,631 888.21 1,497 1,088.10 0.0010
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 6,601 -18,147 -73.33 126 -69.78 0.0001
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 24,748 11,900 92.62 417 113.85 0.0003
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 12,848 -36,940 -74.19 195 -78.11 0.0002
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 49,788 30,366 156.35 891 180.19 0.0009
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 19,422 -20,507 -51.36 318 -43.11 0.0003
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 39,929 23,135 137.76 559 109.36 0.0006
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 16,794 -7,264 -30.19 267 -33.42 0.0003
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 24,058 15,599 184.41 401 322.11 0.0004
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 8,459 3,972 88.52 95 163.89 0.0001
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 4,487 -4,901 -52.20 36 -57.14 0.0001
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 9,388 -16,283 -63.43 84 -70.21 0.0001
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 25,671 -97 -0.38 282 -9.03 0.0003
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 25,768 8,616 50.23 310 101.30 0.0003
2015-05-19 2015-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 17,152 -219,000 -92.74 154 -95.34 0.0002
2015-05-14 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 17,152 154
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 236,152 234,002 10,883.81 3,306 14,273.91 0.0032
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 2,150 -30,707 -93.46 23 -95.63 0.0000
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 32,857 4,088 14.21 526 14.10 0.0006
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 28,769 -299,569 -91.24 461 -88.30 0.0005
2014-02-13 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 328,338 284,142 642.91 3,939 791.18 0.0040
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS COM 921659108 44,196 34,767 368.72 442 481.58 0.0005
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS COM 921659108 9,429 9,429 76 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-02-10 2019-12-31 13F VANDA PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-15 2019-09-30 13F/A VANDA PHARMACEUTICALS OPT Call 1,700 23 n/a n/a n/a
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS OPT Call 1,700 23 n/a n/a n/a
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS OPT Call 1,000 900.00 23 1,050.00 n/a n/a n/a
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS OPT Call 100 -96.30 2 -95.56 n/a n/a n/a
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS OPT Call 2,700 -55.00 45 -50.55 n/a n/a n/a
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS OPT Call 6,000 -14.29 91 -27.20 n/a n/a n/a
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS OPT Call 7,000 6,900.00 125 6,150.00 n/a n/a n/a
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS OPT Call 100 0.00 2 100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS OPT Call 100 -98.80 1 -99.24 n/a n/a n/a
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS OPT Call 8,300 -51.74 132 -54.01 n/a n/a n/a
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS OPT Call 17,200 405.88 287 655.26 n/a n/a n/a
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS OPT Call 3,400 142.86 38 245.45 n/a n/a n/a
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS OPT Call 1,400 -87.27 11 -88.89 n/a n/a n/a
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS OPT Call 11,000 547.06 99 421.05 n/a n/a n/a
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS OPT Call 1,700 -59.52 19 -62.00 n/a n/a n/a
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS OPT Call 4,200 -96.97 50 -95.99 n/a n/a n/a
2015-05-19 2015-03-31 13F/A VANDA PHARMACEUTICALS OPT Call 138,600 -9.17 1,247 -41.62 n/a n/a n/a
2015-05-14 2015-03-31 13F VANDA PHARMACEUTICALS OPT Call 138,600 1,247 n/a n/a n/a
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS OPT Call 152,600 1,130.65 2,136 1,622.58 n/a n/a n/a
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS OPT Call 12,400 -60.88 124 -75.54 n/a n/a n/a
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS OPT Call 31,700 -50.00 507 -50.00 n/a n/a n/a
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS OPT Call 63,400 30.45 1,014 73.93 n/a n/a n/a
2014-02-13 2013-12-31 13F VANDA PHARMACEUTICALS OPT Call 48,600 29.60 583 55.47 n/a n/a n/a
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS OPT Call 37,500 -89.63 375 -87.17 n/a n/a n/a
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS OPT Call 361,700 2,922 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS OPT Put 600 0.00 10 25.00 n/a n/a n/a
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS OPT Put 600 -93.62 8 -94.67 n/a n/a n/a
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS OPT Put 9,400 347.62 150 328.57 n/a n/a n/a
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS OPT Put 2,100 10.53 35 66.67 n/a n/a n/a
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS OPT Put 1,900 0.00 21 40.00 n/a n/a n/a
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS OPT Put 1,900 -92.86 15 -93.72 n/a n/a n/a
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS OPT Put 26,600 14.66 239 -6.27 n/a n/a n/a
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS OPT Put 23,200 -6.83 255 -14.72 n/a n/a n/a
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS OPT Put 24,900 1.22 299 35.29 n/a n/a n/a
2015-05-19 2015-03-31 13F/A VANDA PHARMACEUTICALS OPT Put 24,600 -95.37 221 -97.03 n/a n/a n/a
2015-05-14 2015-03-31 13F VANDA PHARMACEUTICALS OPT Put 24,600 221 n/a n/a n/a
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS OPT Put 531,700 11,715.56 7,444 16,442.22 n/a n/a n/a
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS OPT Put 4,500 -75.54 45 -84.69 n/a n/a n/a
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS OPT Put 18,400 9.52 294 9.29 n/a n/a n/a
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS OPT Put 16,800 -89.37 269 -85.82 n/a n/a n/a
2014-02-13 2013-12-31 13F VANDA PHARMACEUTICALS OPT Put 158,100 19.59 1,897 43.49 n/a n/a n/a
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS OPT Put 132,200 2,394.34 1,322 2,974.42 n/a n/a n/a
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS OPT Put 5,300 43 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.